Status:

COMPLETED

A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions:

HIV Infections

Eligibility:

All Genders

18-60 years

Phase:

PHASE1

Brief Summary

The purpose of this study is to find out whether taking protease inhibitors (anti-HIV drugs) together with lipid-lowering drugs (drugs which lower the amount of fat in the blood) has an effect on the ...

Detailed Description

Potent antiretroviral therapy has become the standard of care for persons with HIV infection and AIDS. Recently, however, a number of complications have emerged with the widespread use of protease inh...

Eligibility Criteria

Inclusion Criteria

You may be eligible for this study if you:

  • Are HIV-negative.
  • Are between the ages of 18 and 60.
  • Agree to use a barrier method of birth control (e.g., a condom) during the study.

Exclusion Criteria

You will not be eligible for this study if you:

  • Have a history of a chronic illness such as high blood pressure, heart disease, arthritis, or diabetes.
  • Are pregnant or breast-feeding.
  • Are taking certain medications.

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

End Date :

March 1 2002

Estimated Enrollment :

56 Patients enrolled

Trial Details

Trial ID

NCT00000941

End Date

March 1 2002

Last Update

October 29 2021

Active Locations (13)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (13 locations)

1

Univ of Southern California / LA County USC Med Ctr

Los Angeles, California, United States, 900331079

2

San Francisco Gen Hosp

San Francisco, California, United States, 941102859

3

Stanford Univ Med Ctr

Stanford, California, United States, 943055107

4

Univ of Colorado Health Sciences Ctr

Denver, Colorado, United States, 80262